Adam Omelianchuk

Sep 9, 2024 | jme.bmj.com | Christopher A Bobier |Adam Omelianchuk |Daniel Hurst

The promise of xenotransplantation: a challenge Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jan 6, 2024 | onlinelibrary.wiley.com | Christopher A Bobier |Daniel Hurst |Daniel Rodger |Adam Omelianchuk

Preclinical xenotransplantation research using genetically engineered pigs has begun to show some promising results and could one day offer a scalable means of addressing organ shortage. While it is a fundamental tenet of ethical human subject research that participants have a right to withdraw from research once enrolled, several scholars have argued that the right to withdraw from xenotransplant research should be suspended because of the public health risks posed by xenozoonotic transmission.